This user has not added any information to their profile yet.
Prof. Dr. Eliangiringa Amos Kaale is Professor of Quality Assurance and Regulatory Affairs in the Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences (MUHAS), and Director/Head of the Pharm R&D Laboratory. He has more than 23 years of experience in pharmaceutical quality assurance, regulatory science, laboratory quality management, medicines-quality surveillance, pharmaceutical manufacturing support, supply-chain quality, capacity building and international technical assistance. His leadership and technical experience includes work with the World Health Organization (WHO), Tanzania Medicines and Medical Devices Authority (TMDA), AUDA-NEPAD/AMRH, United States Pharmacopeia (USP) and regional regulatory initiatives. He served as a Technical Officer in the WHO Norms and Standards for Pharmaceuticals team and is a Member and Rapporteur of the WHO Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP). He chairs the TMDA National Technical Committee for Registration of Human Medicines and the AMRH Regulatory Capacity Development Technical Committee (RCD-TC), coordinates the TMDA–MUHAS Regional Centre of Regulatory Excellence (RCORE), and leads the African Pharmaceutical Laboratory Proficiency Testing Scheme. At MUHAS, he has led the Pharm R&D Laboratory since 2009 and previously served as Head of the Department of Medicinal Chemistry. Prof. Kaale holds a Bachelor of Pharmacy from the University of Dar es Salaam (1997), an MSc in Pharmaceutical Sciences from Katholieke Universiteit Leuven, Belgium (1999), and a PhD in Pharmaceutical Sciences/Pharmacy from Katholieke Universiteit Leuven (2003). He also holds a Postgraduate Diploma in Monitoring and Evaluation Methods from Stellenbosch University, South Africa (2007), and was an Alexander von Humboldt Fellow for Experienced Senior Scientists at Julius Maximilian University of Würzburg, Germany (2012–2014).
-AI-enabled digital regulatory intelligence, machine learning, social listening, detection of online promotion and signals of substandard and falsified medical products, and human-in-the-loop regulatory decision support, including AI-DIGIREG-SF — “AI-Enabled Digital Regulatory Intelligence for Detecting Online Promotion and Signals of Substandard and Falsified Medical Products in Sub-Saharan Africa.”
-Pharmaceutical quality assurance and quality control; pharmaceutical regulatory science and regulatory systems strengthening/harmonization.
-Medicines quality surveillance, post-market surveillance, risk-based testing, and detection/management of substandard and falsified medical products.
-Analytical method development, validation and inter-laboratory cross-validation, including field-adapted and spectroscopic/chromatographic approaches.
-Laboratory quality-management systems, proficiency testing, ISO/IEC 17043, ISO/IEC 17025 and strengthening analytical performance of quality-control laboratories.
-Pharmaceutical manufacturing support, formulation development, bioequivalence, technology transfer and local production of quality-assured medicines.
-Health-product supply-chain quality, storage, cold-chain systems, traceability and quality assurance across procurement and distribution systems.
-Regulatory workforce development, competency frameworks, continuing professional development and regional regulatory capacity building.
-International pharmaceutical norms and standards, pharmacopoeial science, technical guidance and regulatory convergence.
Project Duration Role / funding
Senselet Tanzania Health Supply Chain Management Project 2025–2028 Principal Investigator; funded by Novo Nordisk and Kühne Foundation.
USP Promoting the Quality of Medicines Plus (PQM+) activities 2021–2023 Programme Manager / Team Lead; USAID-supported pharmaceutical quality and regulatory strengthening.
Medicines Regulatory Systems Landscaping and Analytics Support for Africa 2019–2020 Principal Investigator; funded by the Bill & Melinda Gates Foundation.
Bioequivalence Studies of Locally Manufactured Amoxicillin and Captopril Formulations 2018 Co-Principal Investigator; supporting East African pharmaceutical manufacturing.
Muhimbili–Bergen University Partnership to Enhance Pharmacy Education and Research (PEPER) 2018 Principal Investigator.
Strengthening Research Infrastructure in Drug Discovery, Design and Development at MUHAS 2018 Principal Investigator; funded by COSTECH.
HIV Rapid Test Quality Improvement Initiative – Tanzania 2014–2016 Principal Investigator; funded by CDC Atlanta.
In-house Proficiency-Testing Panels for CD4 Testing Laboratories in Tanzania 2013–2014 Principal Investigator; funded by NIMR/Global Fund Round 8.
MUHAS–UCSF Academic Twinning Project 2008–2010 Co-Principal Investigator and M&E Team Leader; funded by the Bill & Melinda Gates Foundation.
MEDISHARE – African Collaborative Epidemiological and Pharmacoepidemiological Observatory on HIV, Tuberculosis and Malaria 2008–2010 Co-Principal Investigator; EU EDULINK.
1. Oriyo N, Ntinginya N, Matiko D, Mmbaga B, Sabiiti W, Masunga E, et al., including Kaale E. The ASCEND Project (2020–2023): Strengthening clinical trial ethics review and pharmacovigilance capacity in Tanzania Mainland and Zanzibar. Open Research Europe. 2026;6:46.
2. Manyanga VP, Nyalali NW, Makoye PM, Sangeda RZ, Masota NE, Daniel IJ, Tibalinda P, Kaale E. The Spatial Distribution and Distance-Based Regulatory Compliance of Private Medicine Outlets in Two Urban Districts of Dar es Salaam, Tanzania. Cureus. 2025;17(12).
3. Kimaro E, Konje ET, Mori AT, Kidenya BR, Kaale E. Investigating Real-World Stability and Sterility of In-Use Insulin—An Urgent Public Health Concern in Sub-Saharan Africa. Diabetes, Metabolic Syndrome and Obesity. 2025;18:3027–3030.
4. Kimaro E, Konje ET, Kidenya BR, Mori AT, Kaale E. Quality of insulin obtained from hospital and community pharmacies in Mwanza, Tanzania: A cross-sectional study. PLoS One. 2025;20(6):e0325366.
5. Kibanga W, Munishi C, Ntissi H, Ndayishimiye P, Myemba DT, Mfinanga E, Mutagonda RF, Kaale E. Vaccine handling practices and conformity to cold chain temperature requirements in selected regions of Tanzania: a descriptive cross-sectional study. Journal of Pharmaceutical Policy and Practice. 2025;18(1):2479062.
6. Fimbo AM, Sillo HB, Nkayamba A, Kisoma S, Mwalwisi YH, Idris R, et al., including Kaale E. Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020. PLOS Global Public Health. 2024;4(10):e0003241.
